心房颤动合并慢性冠状动脉综合征的抗栓治疗进展  

Antithrombotic Therapy for Atrial Fibrillation Complicated with Chronic Coronary Syndrome

作　　者：索妮 杨艳敏[1] SUO Ni;YANG Yanmin(Emergency and Intensive Care Center,Fuwai Hospital,Chinese Academy of Medical Science and Peking Union Medical College,Beijing 100037,China)

机构地区：[1]北京协和医学院中国医学科学院阜外医院急重症中心,北京100037

出　　处：《心血管病学进展》2022年第1期30-32,共3页Advances in Cardiovascular Diseases

基　　金：首都特色应用研究及成果推广(Z171100001017193)。

摘　　要：心房颤动和慢性冠状动脉综合征常合并存在,二者并存时不仅增加卒中和体循环栓塞风险,且心脏缺血事件风险亦高。对于心房颤动合并慢性冠状动脉综合征患者,采取何种抗栓策略及如何权衡缺血及出血风险是临床上亟待明确的问题。近年来针对抗栓治疗的研究越来越多,现结合最新研究证据就心房颤动合并慢性冠状动脉综合征的抗栓治疗做一综述。Atrial fibrillation and chronic coronary syndrome(CCS)often coexist.When they coexist,they not only increase the risk of stroke and systemic embolism,but also increase the risk of cardiac ischemic events.For patients with atrial fibrillation complicated with CCS,what antithrombotic strategy to take and how to balance the risk of ischemia and bleeding are urgent problems in clinic.In recent years,more and more studies on antithrombotic therapy have been carried out.Combined with the latest research evidence,this paper reviews the antithrombotic therapy of atrial fibrillation complicated with CCS.

关 键 词：心房颤动 慢性冠状动脉综合征 抗栓治疗 

分 类 号：R54[医药卫生—心血管疾病]